{
    "clinical_study": {
        "@rank": "154670", 
        "acronym": "SDC lung", 
        "arm_group": [
            {
                "arm_group_label": "Standard"
            }, 
            {
                "arm_group_label": "Standard + saliva collection"
            }
        ], 
        "brief_summary": {
            "textblock": "Introducing standardized data collection (SDC) for lung cancer patients to improve the\n      performance of the prediction models."
        }, 
        "brief_title": "SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Lung Cancer", 
        "condition_browse": {
            "mesh_term": "Lung Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "All patients planned for curative primary or postoperative radiotherapy can be included.\n      Patients will be treated according to the institutional protocol. It is optional to collect\n      a saliva sample for genetic profiling.\n\n      Follow up at five time points:\n\n        -  2 weeks after RT\n\n        -  3 months after RT\n\n        -  6 months after RT\n\n        -  12 months after RT\n\n        -  24 months after RT\n\n      At these time points, toxicity will be assessed. In addition, patients will receive a short\n      questionnaire by mail at eight time points."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients planned for curatively intended radiotherapy or postoperative\n             radiotherapy\n\n          -  Recurrent disease\n\n        Exclusion Criteria:\n\n          -  All patients planned for palliative radiotherapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients planned for curatively intended radiotherapy or postoperative radiotherapy."
            }
        }, 
        "enrollment": {
            "#text": "864", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01855191", 
            "org_study_id": "SDC Lung"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 22, 2014", 
        "location": {
            "contact": {
                "email": "chantal.overhof@maastro.nl", 
                "last_name": "Chantal Overhof-Wedick", 
                "phone": "+31 88 44 55 686"
            }, 
            "contact_backup": {
                "email": "cary.dehing@maastro.nl", 
                "last_name": "Cary Oberije", 
                "phone": "+31 88 44 55 767"
            }, 
            "facility": {
                "address": {
                    "city": "Maastricht", 
                    "country": "Netherlands"
                }, 
                "name": "MAASTRO clinic"
            }, 
            "investigator": {
                "last_name": "Philippe Lambin, MD. PhD.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_groups": "2", 
        "official_title": "Standardized Data Collection (SDC) for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation (SDC Lung).", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Two-year survival rate", 
            "safety_issue": "No", 
            "time_frame": "24 months after RT"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01855191"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in dyspnea", 
                "safety_issue": "No", 
                "time_frame": "during 24 months after RT"
            }, 
            {
                "measure": "Change in cough", 
                "safety_issue": "No", 
                "time_frame": "During 24 months after RT"
            }, 
            {
                "measure": "Change in dysphagia", 
                "safety_issue": "No", 
                "time_frame": "During 24 months after RT"
            }, 
            {
                "description": "Measured by Euroqol questionnaire", 
                "measure": "Patient-rated generic quality of life", 
                "safety_issue": "No", 
                "time_frame": "During 24 months after RT"
            }
        ], 
        "source": "Maastricht Radiation Oncology", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Maastricht Radiation Oncology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}